Publications | CDI Pathogenesis and Therapy - Wang Lab at Biomedical Sciences of HCOM

2024

“ Preliminary Investigations of Microbiologically Influenced Corrosion of 304 Stainless Steel by Anaerobic Clostridioides Difficile Biofilm ”. 2024. International Biodeterioration & Biodegradation .

“ A New Convenient Method to Assess Antibiotic Resistance and Antimicrobial Efficacy Against Pathogenic Clostridioides Difficile Biofilms ”. 2024. Antibiotics .

“ Revealing Roles of S-Layer Protein (SlpA) In Clostridioides Difficile pathogenicity by Generating the First slpA gene Deletion Mutant ”. 2024.

Gurung, Bijay, Maranda Stricklin, and Shaohua Wang. 2024. “ Gut Microbiota–Gut Metabolites And Clostridioides Difficile Infection: Approaching Sustainable Solutions for Therapy ”. Metabolites .

“ Abnormalities in Microbiota/Butyrate/FFAR3 Signaling in Aging Gut Impair Brain Function ”. 2024.

2023

Wang, Shaohua. 2023. “ The Exploration of Low-Dimensional Nanoparticles for Disease Diagnosis and Therapy .”

Wang, Shaohua. 2023. Bacterial strain useful for treatment of age-related conditions , issued 2023.

2022

Wang, Shaohua. 2022. “ Protection of Cognitive Decline and Alzheimer’s Disease Progression by a Human Origin‐probiotic Biotherapy .”

2021

Wang, Shaohua. 2021. “ A Novel Probiotics Therapy for Aging-Related Leaky Gut and Inflammation .”

Wang, Shaohua. 2021. “ Metformin Reduces Clostridium Difficile infection .”

Contact Information:

(740) 593–9381 | Building 21, The Ridges

Ohio University Contact Information:

Ohio University | Athens OH 45701 | 740.593.1000 ADA Compliance | © 2018 Ohio University . All rights reserved.

Ohio University

View Site in Mobile | Classic

Share by: